{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T21:12:32Z","timestamp":1769721152933,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":5278,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.jpainsymman.2005.02.011","type":"journal-article","created":{"date-parts":[[2005,8,26]],"date-time":"2005-08-26T07:27:24Z","timestamp":1125041244000},"page":"192-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Stability of Tramadol and Haloperidol for Continuous Subcutaneous Infusion at Home"],"prefix":"10.1016","volume":"30","author":[{"given":"Sof\u00eda","family":"Negro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luz","family":"Azuara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Barcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2005.02.011_bib1","unstructured":"Care pain relief and palliative care. Technical Report Series 804. WHO, 1990."},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib2","doi-asserted-by":"crossref","first-page":"52A57","DOI":"10.1016\/S0885-3924(98)00024-4","article-title":"Stability of midazolam and fentanyl in infusion solutions","volume":"16","author":"Wilson","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0885-3924(98)00005-0","article-title":"Drug infusors in palliative medicine: A Swedish inquiry","volume":"15","author":"Zachrisson","year":"1998","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1191\/0269216302pm542oa","article-title":"A new method to obtain and present complete information on the compatibility: Study of its validity for eight binary mixtures of morphine with drugs frequently used in palliative care","volume":"16","author":"Vermeire","year":"2002","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib5","series-title":"Applied biopharmaceutics and pharmacokinetics","author":"Shargel","year":"1993"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib6","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.2042-7158.1996.tb05892.x","article-title":"Local tolerance of subcutaneous injections","volume":"48","author":"Fransson","year":"1996","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/beog.2001.0164","article-title":"Acute and chronic pain management in palliative care","volume":"15","author":"Gordin","year":"2001","journal-title":"Best Pract Res Clin Obstetrics Gynaecology"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib8","first-page":"511","article-title":"Tramadol: A step 2 analgesic for chronic pain","volume":"45","author":"Dana","year":"1995","journal-title":"Cancer Bull"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: An update and effects related to mechanism of drug action","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib10","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1212\/WNL.50.6.1842","article-title":"Double blind randomised trial of tramadol for the treatment of the pain of diabetic neuropathy","volume":"50","author":"Harati","year":"1998","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.jpainsymman.2005.02.011_bib11","first-page":"33","article-title":"Chronic pain-challenge and response","volume":"47","author":"Bradford","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/bja\/85.2.211","article-title":"Influence of tramadol on the ventilatory response to hypoxia in humans","volume":"85","author":"Warren","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0885-3924(05)80007-7","article-title":"Subcutaneous infusions for control of cancer symptoms","volume":"5","author":"Storey","year":"1990","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib14","first-page":"511","article-title":"Palliative care (3). Controlling gastrointestinal symptoms","volume":"254","author":"Lord","year":"1995","journal-title":"Pharm J"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0885-3924(92)90074-R","article-title":"Cognitive failure in patients with terminal cancer: A prospective study","volume":"7","author":"Bruera","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<835::AID-CNCR21>3.0.CO;2-#","article-title":"The frequency and clinical course of cognitive impairment in patients with terminal cancer","volume":"79","author":"Pereira","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib17","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archinte.160.6.786","article-title":"Occurrence, causes, and outcome of delirium in patients with advanced cancer. A prospective study","volume":"160","author":"Lawlor","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0885-3924(01)00286-X","article-title":"Sedation for refractory symptoms of terminal cancer patients in Taiwan","volume":"21","author":"Chiu","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib19","first-page":"1019","article-title":"Management of common symptoms in terminally ill patients. Part II: Constipation, delirium and dyspnea","volume":"64","author":"Ross","year":"2001","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib20","first-page":"223","article-title":"Clinical practice recommendations for the management of bowel obstruction in patients with end-stage cancer","volume":"9","author":"Ripamonti","year":"2001","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib21","first-page":"351","article-title":"A retrospective study of the psychiatric management and outcome of delirium in the cancer patient","volume":"4","author":"Olofsson","year":"1996","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib22","first-page":"78","article-title":"Microbial contamination potential of solutions in prefilled disposable syringes used with a syringe pump","volume":"43","author":"Mitriano","year":"1986","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib23","unstructured":"The United States Pharmacopoeia and The National Formulary 26\/21. The United States Pharmacopoeia Convention, Rockville, MD 2003:894."},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1570-0232(02)00065-X","article-title":"Method development and validation of a high-performance liquid chromatographic method for tramadol in human plasma using liquid-liquid extraction","volume":"772","author":"Gan","year":"2002","journal-title":"J Chromatograp B"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib25","unstructured":"FDA. Reviewer guidance: Validation of chromatographic methods. November 1994."},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib26","unstructured":"ICH Q2B. Validation of analytical procedures: Methodology. May 1995."},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib27","series-title":"Pharmaceutical statistics. Practical and clinical applications","author":"Bolton","year":"1984"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/026921639701100306","article-title":"Drug combinations in syringe drivers: the compatibility and stability of diamorphine with cyclizine and haloperidol","volume":"11","author":"Grassby","year":"1997","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0378-5173(98)00264-6","article-title":"Compatibility and stability of morphine in binary admixtures with haloperidol, midazolam, dexamethasone or methylprednisolone","volume":"174","author":"Vermeire","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/026921639100500409","article-title":"The stability of diamorphine alone and in combination with anti-emetics in plastic syringes","volume":"5","author":"Allwood","year":"1991","journal-title":"Palliative Med"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib31","first-page":"2963","article-title":"Compatibility of hydromorphone hydrochloride with haloperidol lactate and ketorolac tromethamine","volume":"51","author":"Huang","year":"1994","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib32","first-page":"905","article-title":"Visual compatibility of haloperidol lactate with injectable solutions","volume":"51","author":"Fraser","year":"1994","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib33","first-page":"65","article-title":"Physical compatibility and in vivo evaluation of drug mixtures for subcutaneous infusion to cancer patients in palliative care","volume":"10","author":"Negro","year":"2002","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib34","first-page":"107","article-title":"Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care","volume":"11","author":"Barcia","year":"2003","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib35","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/10826079708014142","article-title":"High performance liquid chromatography determination of tramadol in pharmaceutical dosage forms","volume":"20","author":"Zaghlouol","year":"1997","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib36","first-page":"75","article-title":"Stability study of tramadol in PVC infusion bags","volume":"18","author":"Muller","year":"1997","journal-title":"KrankenhausPharmazie"},{"key":"10.1016\/j.jpainsymman.2005.02.011_bib37","series-title":"Tramadol analytical research standards","year":"1999"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539240500237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539240500237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:55:52Z","timestamp":1760129752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088539240500237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S088539240500237X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2005.02.011","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stability of Tramadol and Haloperidol for Continuous Subcutaneous Infusion at Home","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2005.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}